We are live on ! Find out more
PP

Paloma Partners Portfolio holdings

AUM $510M
1-Year Est. Return 286.05%
This Fund
S&P 500
This Quarter Est. Return
+5.02%
1 Year Est. Return
+286.05%
3 Year Est. Return
+321.92%
5 Year Est. Return
+284.54%
10 Year Est. Return
+855.7%
AUM
$3.78B
AUM Growth
-$541M
Cap. Flow
-$699M
Cap. Flow %
-18.5%
Top 10 Hldgs %
26.03%
Holding
2,134
New
570
Increased
494
Reduced
496
Closed
467

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$28.7M
2
FXE icon
Invesco CurrencyShares Euro Currency Trust
FXE
+$23.2M
3
BIIB icon
Biogen
BIIB
+$20.8M
4
NKE icon
Nike
NKE
+$18.3M
5
IBM icon
IBM
IBM
+$17.2M

Sector Composition

Rank Sector Weight
1 Healthcare 6.62%
2 Industrials 6.54%
3 Financials 6.19%
4 Technology 6.15%
5 Consumer Discretionary 5.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PG icon
476
Procter & Gamble
PG
$340B
$1.49M 0.04%
+18,706
New +$1.43M
FXI icon
477
iShares China Large-Cap ETF
FXI
$4.32B
$1.48M 0.04%
+42,000
New +$1.58M
FDX icon
478
FedEx
FDX
$73B
$1.48M 0.04%
9,927
-7,338
-43% -$1.13M
LNC icon
479
Lincoln National
LNC
$7.92B
$1.48M 0.04%
29,363
+22,515
+329% +$1.18M
SBH icon
480
Sally Beauty Holdings
SBH
$1.47B
$1.47M 0.04%
52,741
+754
+1% +$18.9K
GL icon
481
Globe Life
GL
$14B
$1.46M 0.04%
25,625
-14,153
-36% -$829K
MTG icon
482
MGIC Investment
MTG
$6.47B
$1.46M 0.04%
165,559
+109,404
+195% +$1.03M
PFG icon
483
Principal Financial Group
PFG
$24.3B
$1.45M 0.04%
32,274
+26,070
+420% +$1.27M
NPBC
484
DELISTED
NATL PENN BANCSHARES INC
NPBC
$1.45M 0.04%
117,670
+106,946
+997% +$1.31M
MESG
485
DELISTED
XURA INC COM (DE)
MESG
$1.45M 0.04%
58,797
-90,564
-61% -$2.26M
GS icon
486
CALL
Goldman Sachs
GS
$289B
$1.44M 0.04%
+8,000
New +$1.49M
GS icon
487
PUT
Goldman Sachs
GS
$289B
$1.44M 0.04%
8,000
-19,300
-71% -$3.59M
SBUX icon
488
CALL
Starbucks
SBUX
$119B
$1.44M 0.04%
24,000
-12,000
-33% -$731K
OIS icon
489
Oil States International
OIS
$466M
$1.44M 0.04%
+52,816
New +$1.57M
NTGR icon
490
NETGEAR
NTGR
$612M
$1.44M 0.04%
34,263
+15,052
+78% +$608K
AEE icon
491
Ameren
AEE
$30.4B
$1.43M 0.04%
+33,099
New +$1.44M
OPK icon
492
Opko Health
OPK
$1.02B
$1.43M 0.04%
+141,983
New +$1.42M
NVR icon
493
NVR
NVR
$17.1B
$1.42M 0.04%
861
-146
-14% -$239K
OCSL icon
494
Oaktree Specialty Lending
OCSL
$1.05B
$1.41M 0.04%
73,863
-418
-0.6% -$7.72K
LLL
495
DELISTED
L3 Technologies, Inc.
LLL
$1.41M 0.04%
11,811
+4,363
+59% +$518K
EFA icon
496
PUT
iShares MSCI EAFE ETF
EFA
$76.4B
$1.41M 0.04%
+24,000
New +$1.45M
EIX icon
497
Edison International
EIX
$30.3B
$1.41M 0.04%
23,802
+17,591
+283% +$1.08M
DST
498
DELISTED
DST Systems Inc.
DST
$1.41M 0.04%
24,628
+6,040
+32% +$355K
UGI icon
499
UGI
UGI
$7.87B
$1.4M 0.04%
41,566
+29,552
+246% +$1.03M
IPG
500
DELISTED
Interpublic Group of Companies
IPG
$1.4M 0.04%
60,131
+3,198
+6% +$71.9K

Similar funds

Paloma Partners's Q4 2015 Portfolio in Review

As of Q4 2015, Paloma Partners held 2,134 positions worth $3.78B, down 13% from $4.32B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Paloma Partners withdrew a net $699M in Q4 2015, closing 467 positions and reducing 496 holdings. Its most notable exit was SIGMA - ALDRICH CORP, an estimated $48.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 6.6% of assets, up from 5.8% a quarter earlier, followed by Industrials and Financials.

Against the trend, Paloma Partners opened a new position in Allergan plc worth $30.1M.

  • Paloma Partners's largest Q4 2015 buy was Allergan plc: 96,344 shares worth $30.1M.
  • Paloma Partners added most to Biogen in Q4 2015, an estimated $20.8M increase.
  • Paloma Partners's biggest Q4 2015 reduction was Regeneron Pharmaceuticals, cutting an estimated $46.2M.
  • Paloma Partners fully exited SIGMA - ALDRICH CORP in Q4 2015, selling an estimated $48.6M.
  • Paloma Partners's ten largest holdings make up 26% of its $3.78B portfolio in Q4 2015.
  • Paloma Partners opened 570 new positions and closed 467 in Q4 2015.
  • Paloma Partners's portfolio value fell 13% quarter-over-quarter to $3.78B.

Based on Paloma Partners's 13F filing for Q4 2015, filed 16 Feb 2016.